The Clorox Company (NYSE:CLX) Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS decreased its position in The Clorox Company (NYSE:CLX) by 1.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 217,521 shares of the company’s stock after selling 2,263 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Clorox were worth $35,436,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. SG Americas Securities LLC lifted its position in Clorox by 1,525.7% during the first quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after buying an additional 61,576 shares during the period. Mizuho Markets Americas LLC raised its position in shares of Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after buying an additional 34,864 shares during the period. CANADA LIFE ASSURANCE Co boosted its holdings in Clorox by 15.2% in the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after acquiring an additional 18,687 shares during the last quarter. Advisors Asset Management Inc. boosted its holdings in Clorox by 257.5% in the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after acquiring an additional 8,087 shares during the last quarter. Finally, Raymond James & Associates increased its stake in Clorox by 32.8% during the second quarter. Raymond James & Associates now owns 267,632 shares of the company’s stock worth $36,524,000 after acquiring an additional 66,149 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.57% of the company’s stock.

Clorox Price Performance

Shares of NYSE CLX traded up $0.12 during midday trading on Thursday, reaching $162.82. The company’s stock had a trading volume of 39,454 shares, compared to its average volume of 1,240,091. The company has a market cap of $20.15 billion, a price-to-earnings ratio of 56.69, a price-to-earnings-growth ratio of 3.11 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a one year low of $127.60 and a one year high of $169.09. The company has a 50 day moving average price of $161.89 and a 200 day moving average price of $146.58.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the firm earned $0.49 EPS. The company’s revenue was up 27.0% on a year-over-year basis. On average, equities research analysts expect that The Clorox Company will post 6.81 EPS for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.00%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 170.03%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. DA Davidson lifted their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Barclays upped their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus target price of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.